| Code | Description | Claims | Beneficiaries | Total Paid |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,905 |
4,844 |
$546K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,098 |
9,811 |
$182K |
| 99233 |
Prolong inpt eval add15 m |
5,108 |
2,136 |
$137K |
| 99223 |
Prolong inpt eval add15 m |
2,400 |
2,269 |
$116K |
| 93000 |
|
4,345 |
4,281 |
$86K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
349 |
344 |
$86K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,383 |
1,118 |
$69K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
372 |
366 |
$55K |
| 93224 |
|
616 |
612 |
$52K |
| 93458 |
|
252 |
250 |
$48K |
| 93880 |
|
385 |
383 |
$43K |
| 93015 |
|
590 |
584 |
$40K |
| 93351 |
|
154 |
152 |
$28K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
658 |
646 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
411 |
405 |
$20K |
| J2785 |
Injection, regadenoson, 0.1 mg |
91 |
91 |
$12K |
| 99442 |
|
742 |
728 |
$6K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
24 |
12 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
100 |
100 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
24 |
24 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
17 |
17 |
$973.74 |
| 99152 |
|
25 |
24 |
$834.28 |
| 93016 |
|
27 |
27 |
$420.52 |
| 93018 |
|
27 |
27 |
$317.84 |
| 99443 |
|
75 |
72 |
$296.64 |